Eucalyptus Co-founder Tim Doyle Says AI Means Australian Start-ups Can Go Global
The Australian Financial Review
READ
Details
- Date Published
- 30 Mar 2026
- Priority Score
- 2
- Australian
- Yes
- Created
- 30 Mar 2026, 08:00 am
Description
The co-founder of healthcare start-up Eucalyptus says its $1.6 billion sale is proof global health businesses can be built locally, but regulation is too slow.
Summary
The sale of healthcare start-up Eucalyptus for $1.6 billion highlights how AI-driven operational efficiencies are enabling Australian firms to scale rapidly and compete in international markets. While the acquisition signals a milestone for the local venture capital ecosystem, it underscores a growing tension between fast-moving frontier AI applications in healthcare and lagging regulatory frameworks. The discussion emphasizes the need for responsive governance to keep pace with AI-enabled medical technologies to ensure both competitiveness and safety. Such rapid global expansion of AI healthcare tools carries implications for cross-border data governance and the oversight of automated clinical decision-making.
Body
TechnologyHealthcare SummitPrint articlePaul Smith and Edmund TadrosMar 30, 2026 – 5.46pmThe co-founder of Eucalyptus says artificial intelligence is making it much easier to expand quickly overseas and could help Australia emerge as a base for successful healthcare start-ups like his own, which was sold to New York-listed obesity drug giant Hims & Hers Health for $1.6 billion.Appearing at The Australian Financial Review Healthcare Summit a month after his company was bought out in one of the biggest-ever deals for the local venture capital sector, Tim Doyle said the sale should be a signal to entrepreneurs and investors that global companies could grow locally.Loading...SaveLog in or Subscribe to save articleShareCopy linkCopiedEmailLinkedInTwitterFacebookCopy linkCopiedShare via...Gift this articleSubscribe to gift this articleGift 5 articles to anyone you choose each month when you subscribe.Subscribe nowAlready a subscriber? LoginLicense articleFollow the topics, people and companies that matter to you.Find out moreRead MoreHealthcare SummitAISoftwareHealthcareMedicineStart-upsWeight lossRegulationFetching latest articles